Literature DB >> 20943989

Cyclin T1/CDK9 interacts with influenza A virus polymerase and facilitates its association with cellular RNA polymerase II.

Junjie Zhang1, Gang Li, Xin Ye.   

Abstract

Influenza virus RNA-dependent RNA polymerase scavenges the 5' cap from host pre-mRNA to prime viral transcription initiation. It is also well established that viral RNA-dependent RNA polymerase (vRNP) associates with cellular RNA polymerase II (Pol II), on which viral replication depends. Here we report that cyclin T1/CDK9 can interact with influenza virus polymerase and facilitate its association with cellular Pol II. The immunodepletion of cyclin T1/CDK9 totally abolished the association of vRNP with the C-terminal domain (CTD) Ser-2-phosphorylated form of RNA polymerase II. Further studies showed that overexpression of cyclin T1/CDK9 increased the transcription activity of vRNP, while knockdown of cyclin T1/CDK9 impaired viral replication. Our results suggest that cyclin T1/CDK9 serves as an adapter to mediate the interaction of vRNP and RNA Pol II and promote viral transcription.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943989      PMCID: PMC3004352          DOI: 10.1128/JVI.01696-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II.

Authors:  A Rodriguez; A Pérez-González; A Nieto
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

Review 2.  Interplay between positive and negative elongation factors: drawing a new view of DRB.

Authors:  Y Yamaguchi; T Wada; H Handa
Journal:  Genes Cells       Date:  1998-01       Impact factor: 1.891

3.  The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.

Authors:  Z Yang; Q Zhu; K Luo; Q Zhou
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

4.  Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus.

Authors:  M Kurokawa; H Ochiai; K Nakajima; S Niwayama
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

5.  Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).

Authors:  Ya-Lin Chiu; Hong Cao; Jean-Marc Jacque; Mario Stevenson; Tariq M Rana
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  RuvB-like protein 2 is a suppressor of influenza A virus polymerases.

Authors:  Satoshi Kakugawa; Masayuki Shimojima; Gabriele Neumann; Hideo Goto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

7.  The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit.

Authors:  Alexandre Dias; Denis Bouvier; Thibaut Crépin; Andrew A McCarthy; Darren J Hart; Florence Baudin; Stephen Cusack; Rob W H Ruigrok
Journal:  Nature       Date:  2009-02-04       Impact factor: 49.962

8.  Nuclear dynamics of influenza A virus ribonucleoproteins revealed by live-cell imaging studies.

Authors:  Eva M Loucaides; Johann C von Kirchbach; Agnes Foeglein; Jane Sharps; Ervin Fodor; Paul Digard
Journal:  Virology       Date:  2009-09-09       Impact factor: 3.616

9.  Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells.

Authors:  Frank T Vreede; Annie Y Chan; Jane Sharps; Ervin Fodor
Journal:  Virology       Date:  2009-10-28       Impact factor: 3.616

10.  Individual influenza A virus mRNAs show differential dependence on cellular NXF1/TAP for their nuclear export.

Authors:  Eliot K C Read; Paul Digard
Journal:  J Gen Virol       Date:  2010-01-13       Impact factor: 3.891

View more
  25 in total

1.  Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network.

Authors:  Lionel Tafforeau; Thibault Chantier; Fabrine Pradezynski; Johann Pellet; Philippe E Mangeot; Pierre-Olivier Vidalain; Patrice Andre; Chantal Rabourdin-Combe; Vincent Lotteau
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

2.  A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.

Authors:  Wen-Chi Su; Shih-Feng Hsu; Yi-Yuan Lee; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

Review 3.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

4.  A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.

Authors:  Shih-Feng Hsu; Wen-Chi Su; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

5.  Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly.

Authors:  Judith Verhelst; Eef Parthoens; Bert Schepens; Walter Fiers; Xavier Saelens
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

6.  Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.

Authors:  Olivia Perwitasari; Xiuzhen Yan; Jason O'Donnell; Scott Johnson; Ralph A Tripp
Journal:  Assay Drug Dev Technol       Date:  2015-07-20       Impact factor: 1.738

7.  Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.

Authors:  Miao Xu; Emily M Lee; Zhexing Wen; Yichen Cheng; Wei-Kai Huang; Xuyu Qian; Julia Tcw; Jennifer Kouznetsova; Sarah C Ogden; Christy Hammack; Fadi Jacob; Ha Nam Nguyen; Misha Itkin; Catherine Hanna; Paul Shinn; Chase Allen; Samuel G Michael; Anton Simeonov; Wenwei Huang; Kimberly M Christian; Alison Goate; Kristen J Brennand; Ruili Huang; Menghang Xia; Guo-Li Ming; Wei Zheng; Hongjun Song; Hengli Tang
Journal:  Nat Med       Date:  2016-08-29       Impact factor: 53.440

8.  Weighted enrichment method for prediction of transcription regulators from transcriptome and global chromatin immunoprecipitation data.

Authors:  Eiryo Kawakami; Shinji Nakaoka; Tazro Ohta; Hiroaki Kitano
Journal:  Nucleic Acids Res       Date:  2016-04-30       Impact factor: 16.971

9.  CHD6, a cellular repressor of influenza virus replication, is degraded in human alveolar epithelial cells and mice lungs during infection.

Authors:  Roberto Alfonso; Ariel Rodriguez; Paloma Rodriguez; Thomas Lutz; Amelia Nieto
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

10.  CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.

Authors:  Makoto Yamamoto; Hiroshi Onogi; Isao Kii; Suguru Yoshida; Kei Iida; Hiroyuki Sakai; Minako Abe; Toshiaki Tsubota; Nobutoshi Ito; Takamitsu Hosoya; Masatoshi Hagiwara
Journal:  J Clin Invest       Date:  2014-07-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.